-
Notifications
You must be signed in to change notification settings - Fork 0
Expand file tree
/
Copy pathSOURCES.yaml
More file actions
254 lines (231 loc) · 10.7 KB
/
SOURCES.yaml
File metadata and controls
254 lines (231 loc) · 10.7 KB
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
# Literature sources for wound module
closure_kinetics_punch_biopsy:
description: Re-epithelialization trajectory (% wound closure over 28 days)
consensus: data/closure_kinetics_punch_biopsy.csv
raw_files:
- data/raw/closure/eaglstein1978_closure.csv
- data/raw/closure/cukjati2000_closure.csv
- data/raw/closure/pastar2014_closure.csv
columns:
- day
- closure_pct
units:
day: days
closure_pct: percent
normalization: absolute (0-100%)
sources:
- id: eaglstein1978
authors: Eaglstein WH, Mertz PM
year: 1978
title: New methods for assessing epidermal wound healing
journal: J Invest Dermatol 71(6):382-384
doi: 10.1111/1523-1747.ep12556814
- id: cukjati2000
authors: Cukjati D, Rebersek S, Karba R, Miklavcic D
year: 2000
title: Modelling of chronic wound healing dynamics
journal: Med Biol Eng Comput 38(3):339-347
doi: 10.1007/BF02347056
- id: pastar2014
authors: Pastar I, Stojadinovic O, Yin NC, Ramirez H, Nusbaum AG, Sawaya A, Patel SB, Khalid L, Isseroff RR, Tomic-Canic
M
year: 2014
title: 'Epithelialization in wound healing: a comprehensive review'
journal: Adv Wound Care 3(7):445-464
doi: 10.1089/wound.2013.0473
normal_skin_profile:
description: 'Literature sources for baseline normal skin parameters: cell cycle kinetics, stem/TA cell hierarchy, calcium-driven
differentiation, and paracrine growth factor signaling.
'
sources:
- id: dover1988
authors: Dover R, Potten CS
year: 1988
title: Heterogeneity and cell cycle analyses from time-lapse studies of human keratinocytes in vitro
journal: J Cell Sci 89(3):359-371
doi: 10.1242/jcs.89.3.359
notes: 'Time-lapse cell cycle analysis of human keratinocytes. Mean cycle time ~17h with heterogeneity. Supports g1_duration=7.0,
s_duration=6.0, g2_duration=3.0, m_duration=1.0 parameters.
'
- id: potten1988
authors: Potten CS, Morris RJ
year: 1988
title: Epithelial stem cells in vivo
journal: J Cell Sci Suppl 10:45-62
doi: 10.1242/jcs.1988.supplement_10.4
notes: 'Epidermal proliferative unit model: stem cells with unlimited self-renewal, TA cells with 3-5 divisions before
terminal differentiation. Supports max_ta_divisions=4, p_asymmetric=0.7.
'
- id: bikle2012
authors: Bikle DD, Xie Z, Tu CL
year: 2012
title: Calcium regulation of keratinocyte differentiation
journal: Expert Rev Endocrinol Metab 7(4):461-472
doi: 10.1586/eem.12.34
notes: 'Calcium gradient from low (basal) to peak (granulosum) drives sequential keratinocyte differentiation via CaR
signaling. Supports calcium_basal=0.05, calcium_peak=1.5 and differentiation threshold parameters.
'
- id: finch2004
authors: Finch PW, Rubin JS
year: 2004
title: Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial
protection and repair
journal: Adv Cancer Res 91:69-136
doi: 10.1016/S0065-230X(04)91003-2
notes: 'KGF (FGF-7) is a paracrine factor from mesenchymal cells that drives epithelial proliferation and repair. Supports
kgf_basal_conc and kgf_max_boost parameters.
'
aged_skin_profile:
description: 'Literature sources for aged skin profile parameters. Aged skin shows slower epidermal turnover, thinner stratum
corneum, and reduced dermal vasculature compared to young adult skin.
'
sources:
- id: gilchrest1983
authors: Gilchrest BA
year: 1983
title: In vitro assessment of keratinocyte aging
journal: J Invest Dermatol 81(1 Suppl):184s-189s
doi: 10.1111/1523-1747.ep12541084
notes: 'Aged keratinocytes proliferate more slowly in vitro with reduced mitogenic responsiveness. Supports g1_duration=9.0
and s_duration=8.0 (total cycle ~20h vs ~17h in young adult).
'
- id: farage2013
authors: Farage MA, Miller KW, Elsner P, Maibach HI
year: 2013
title: Characteristics of the aging skin
journal: Adv Wound Care 2(1):5-10
doi: 10.1089/wound.2011.0356
notes: 'Review of age-related skin changes: thinner stratum corneum, reduced barrier function, slower transepidermal water
loss recovery. Supports volume_z_cornified=20.0, water_recovery_rate=0.03, and basal perfusion=0.8 parameters.
'
- id: sgonc2013
authors: Sgonc R, Gruber J
year: 2013
title: 'Age-related aspects of cutaneous wound healing: a mini-review'
journal: Gerontology 59(2):159-164
doi: 10.1159/000342344
notes: 'Fewer active stem cells, reduced growth factor responsiveness, and delayed inflammatory resolution in aged skin.
Supports stem_fraction=0.30 parameter.
'
treatment_interventions:
description: 'Literature sources supporting treatment parameter choices for diabetic wound interventions. Each treatment
overlay modifies diabetic dysfunction parameters proportional to published clinical/preclinical effect sizes.
'
sources:
- id: goren2007
authors: Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, Muhl H, Frank S
year: 2007
title: Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages
journal: J Invest Dermatol 127(9):2259-2267
doi: 10.1038/sj.jid.5700842
notes: 'Anti-TNF-alpha restores wound healing in diabetic ob/ob mice via macrophage inactivation. Supports anti_inflammatory
treatment m1_duration_factor and resolution_factor adjustments.
'
- id: ashcroft2012
authors: Ashcroft GS, Jeong MJ, Ashworth JJ, Hardman M, Jin W, Moutsopoulos N, et al.
year: 2012
title: Tumor necrosis factor-alpha (TNF-alpha) is a therapeutic target for impaired cutaneous wound healing
journal: Wound Repair Regen 20(1):38-49
doi: 10.1111/j.1524-475X.2011.00748.x
notes: 'Topical anti-TNF-alpha neutralizing antibodies blunt leukocyte recruitment, shift M1/M2 balance, and accelerate
wound closure.
'
- id: siqueira2010
authors: Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, et al.
year: 2010
title: Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced
activation of forkhead box O1 (FOXO1)
journal: Diabetologia 53(2):378-388
doi: 10.1007/s00125-009-1529-y
notes: 'TNF-alpha dysregulation drives fibroblast apoptosis and reduced proliferation via FOXO1 pathway in diabetic wounds.
'
- id: londahl2010
authors: Londahl M, Katzman P, Nilsson A, Hammarlund C
year: 2010
title: Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes
journal: Diabetes Care 33(5):998-1003
doi: 10.2337/dc09-1754
notes: 'HODFU RCT: HBO significantly improved complete healing of chronic DFUs at 1 year. Supports HBO treatment perfusion
and VEGF adjustments.
'
- id: fedorko2016
authors: Fedorko L, Bowen JM, Jones W, Englesbe G, Englesbe J, Dain S, et al.
year: 2016
title: Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing
ulcers of the lower limb
journal: Diabetes Care 39(3):392-399
doi: 10.2337/dc15-2001
notes: 'Negative RCT: no significant healing difference with HBO. Provides important context that HBO effect sizes are
debated.
'
- id: morykwas1997
authors: Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W
year: 1997
title: 'Vacuum-assisted closure: a new method for wound control and treatment'
journal: Ann Plast Surg 38(6):553-562
doi: 10.1097/00000637-199706000-00001
notes: 'Original NPWT description. 4x blood flow increase at -125 mmHg. Granulation tissue formation accelerated. Supports
NPWT perfusion and proliferation parameter adjustments.
'
- id: armstrong2005
authors: Armstrong DG, Lavery LA
year: 2005
title: Negative pressure wound therapy after partial diabetic foot amputation
journal: Lancet 366(9498):1704-1710
doi: 10.1016/S0140-6736(05)67695-7
notes: 'RCT: NPWT improved healing rate (56% vs 39%) in diabetic foot amputations. Supports NPWT treatment parameter magnitudes.
'
- id: smith1999
authors: Smith GN Jr, Mickler EA, Hasty KA, Brandt KD
year: 1999
title: Specificity of inhibition of matrix metalloproteinase activity by doxycycline
journal: Arthritis Rheum 42(6):1140-1146
doi: 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7
notes: 'Sub-antimicrobial doxycycline inhibits MMP-1, -8, -9, -13. IC50 values support mmp_factor adjustment from 3.0
to 1.5.
'
- id: steed2006
authors: Steed DL
year: 2006
title: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers
journal: Plast Reconstr Surg 117(7 Suppl):143S-149S
doi: 10.1097/01.prs.0000222526.21512.4c
notes: 'Becaplermin (rhPDGF-BB) improved complete healing in DFU clinical trials. Supports growth_factor treatment fibroblast
activation and density parameters.
'
- id: smiell1998
authors: Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH
year: 1998
title: Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing,
lower extremity diabetic ulcers
journal: Wound Repair Regen 7(5):335-346
doi: 10.1046/j.1524-475X.1999.00335.x
notes: 'FDA pivotal trial data for becaplermin. 50% improvement in complete healing vs. placebo.
'
- id: cao2017
authors: Cao Y, Gang X, Sun C, Wang G
year: 2017
title: Mesenchymal stem cells improve healing of diabetic foot ulcer
journal: J Diabetes Res 2017:9328347
doi: 10.1155/2017/9328347
notes: 'Review of MSC mechanisms in DFU: paracrine factors (VEGF, PDGF, TGF-beta, IL-10) modulate all four dysfunction
axes.
'
- id: winter1962
authors: Winter GD
year: 1962
title: Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig
journal: Nature 193:293-294
doi: 10.1038/193293a0
notes: 'Foundational moist wound healing study. Epithelialization 2x faster under occlusive dressing vs. air-exposed.
Supports moisture treatment water_recovery_rate and surface_loss_rate adjustments.
'
- id: junker2013
authors: Junker JPE, Kamel RA, Caterson EJ, Eriksson E
year: 2013
title: Clinical impact upon wound healing and inflammation in moist, wet, and dry environments
journal: Adv Wound Care 2(7):348-356
doi: 10.1089/wound.2012.0412
notes: 'Moist environment reduces inflammation, improves keratinocyte migration, and accelerates wound closure. Supports
moisture treatment inflammation_decay adjustment.
'